{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T03:56:10Z","timestamp":1781236570674,"version":"3.54.1"},"reference-count":14,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.jiac.2014.05.002","type":"journal-article","created":{"date-parts":[[2014,6,13]],"date-time":"2014-06-13T14:30:54Z","timestamp":1402669854000},"page":"541-548","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Efficacy and safety of garenoxacin tablets on clinically diagnosed atypical pneumonia: Postmarketing surveillance in Japan"],"prefix":"10.1016","volume":"20","author":[{"given":"Koichi","family":"Izumikawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoyuki","family":"Miyashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Hosono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Kushimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Kohno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2014.05.002_bib1","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1128\/AAC.43.5.1077","article-title":"In\u00a0vitro and in\u00a0vivo antimicrobial activities of T-3811ME, a novel des-F(6)-quinolone","volume":"43","author":"Takahata","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"issue":"S-1","key":"10.1016\/j.jiac.2014.05.002_bib2","first-page":"1","article-title":"In\u00a0vitro antibacterial activity of garenoxacin","volume":"55","author":"Takahata","year":"2007","journal-title":"Jpn J Chemother"},{"issue":"S-1","key":"10.1016\/j.jiac.2014.05.002_bib3","first-page":"95","article-title":"Phase 1 clinical studies of oral garenoxacin in healthy Japanese adult subjects","volume":"55","author":"Uchida","year":"2007","journal-title":"Jpn J Chemother"},{"issue":"S-1","key":"10.1016\/j.jiac.2014.05.002_bib4","first-page":"162","article-title":"Penetration into sputum study of garenoxacin in patients with secondary infection of chronic respiratory disease","volume":"55","author":"Watanabe","year":"2007","journal-title":"Jpn J Chemother"},{"issue":"S-1","key":"10.1016\/j.jiac.2014.05.002_bib5","first-page":"194","article-title":"Clinical phase III open-label study of oral garenoxacin in patients with otorhinolaryngological infection","volume":"55","author":"Baba","year":"2007","journal-title":"Jpn J Chemother"},{"key":"10.1016\/j.jiac.2014.05.002_bib6","first-page":"111","article-title":"Pharmacological properties and clinical efficacy of garenoxacin mesilate hydrate (Geninax\u00ae Tablet 200\u00a0mg), a quinolone antimicrobial","volume":"132","author":"Tsuda","year":"2008","journal-title":"Jpn J Pharmacol"},{"issue":"S-1","key":"10.1016\/j.jiac.2014.05.002_bib7","first-page":"116","article-title":"Clinical phase II study of garenoxacin in patients with respiratory tract infections. \u2014open-label, multi-center, non-comparative\u2014","volume":"55","author":"Kobayashi","year":"2007","journal-title":"Jpn J Chemother"},{"issue":"S-1","key":"10.1016\/j.jiac.2014.05.002_bib8","first-page":"169","article-title":"Clinical phase III study of oral garenoxacin in patients with community-acquired acute respiratory infection","volume":"55","author":"Kobayashi","year":"2007","journal-title":"Jpn J Chemother"},{"key":"10.1016\/j.jiac.2014.05.002_bib9","first-page":"S79","article-title":"Guidelines for the management of community acquired pneumonia in adults (revised edition)","volume":"11","author":"Committee for The Japanese Respiratory Society guidelines for the management of Respiratory Infections","year":"2006","journal-title":"Respirology"},{"key":"10.1016\/j.jiac.2014.05.002_bib10","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s101560050020","article-title":"Clinical evaluation methods for new antimicrobial agents to treat respiratory infections: report of the Committee for the Respiratory System, Japan Society of Chemotherapy","volume":"5","author":"Saito","year":"1999","journal-title":"J\u00a0Infect Chemother"},{"key":"10.1016\/j.jiac.2014.05.002_bib11","first-page":"614","article-title":"Safety and efficacy of levofloxacin 500\u00a0mg once a day","volume":"59","author":"Hori","year":"2011","journal-title":"Jpn J Chemother"},{"key":"10.1016\/j.jiac.2014.05.002_bib12","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s10156-010-0184-z","article-title":"Multicenter surveillance of adult atypical pneumonia in Japan: its clinical features, and efficacy and safety of clarithromycin","volume":"17","author":"Goto","year":"2011","journal-title":"J\u00a0Infect Chemother"},{"key":"10.1016\/j.jiac.2014.05.002_bib13","first-page":"646","article-title":"Postmarketing surveillance for clarithromycin in patients with community-acquired pneumonia","volume":"60","author":"Goto","year":"2012","journal-title":"Jpn J Chemother"},{"key":"10.1016\/j.jiac.2014.05.002_bib14","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1128\/JCM.43.5.2277-2285.2005","article-title":"Evaluation of 12 commercial tests and the complement fixation test for Mycoplasma pneumoniae-specific immunoglobulin G (IgG) and IgM antibodies, with PCR used as the \u201cgold standard\u201d","volume":"43","author":"Beersma","year":"2005","journal-title":"J\u00a0Clin Microbiol"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X14001901?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X14001901?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:52:17Z","timestamp":1761159137000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X14001901"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":14,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S1341321X14001901"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2014.05.002","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of garenoxacin tablets on clinically diagnosed atypical pneumonia: Postmarketing surveillance in Japan","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2014.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}